Back to Avoro Capital Advisors LLC

TSHA
Showing 8 of 11 quarters

Position history for Avoro Capital Advisors LLC's holdings in TAYSHA GENE THERAPIES INC

Avoro Capital Advisors LLC holds 21.7M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $97M as of 2026-Q1. TSHA represents 1.0% of Avoro Capital Advisors LLC's portfolio.

Current Value

$97M

Current Shares

21.7M

Total Value Change

+$55.2M

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
21.7M
0.0%
$97M1.0%$4.53
0
2025-Q4
Unchanged
21.7M
0.0%
$119.4M1.2%$5.66
0
2025-Q3
Unchanged
21.7M
0.0%
$71M0.9%$3.16
0
2025-Q2
Increased
21.7M
+8.5%
$50.1M0.9%$2.38
46
2025-Q1
Unchanged
20M
0.0%
$27.8M0.4%$1.93
0
2024-Q4
Increased
20M
+7.2%
$34.6M0.5%$1.73
38
2024-Q3
Unchanged
18.7M
0.0%
$37.5M0.5%$2.07
0
2024-Q2
Unchanged
18.7M
0.0%
$41.8M0.6%$2.24
0

Other major holders of TSHA: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., GOLDMAN SACHS GROUP INC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used